Shares of Trupanion Inc (NYSE:TRUP) have been assigned a consensus rating of “Buy” from the eight brokerages that are currently covering the company. Two analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $15.57.

Several research analysts have commented on the stock. RBC Capital Markets set a $18.00 price objective on shares of Trupanion and gave the company a “buy” rating in a research report on Tuesday, September 20th. Stifel Nicolaus boosted their target price on shares of Trupanion from $17.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, August 3rd. Canaccord Genuity reaffirmed a “buy” rating and set a $19.00 target price on shares of Trupanion in a research note on Thursday, August 4th. Zacks Investment Research cut shares of Trupanion from a “buy” rating to a “hold” rating in a research note on Wednesday, July 27th. Finally, Lake Street Capital initiated coverage on shares of Trupanion in a research note on Tuesday, July 19th. They set a “buy” rating and a $18.00 target price on the stock.

In related news, CEO Darryl Rawlings sold 3,500 shares of the business’s stock in a transaction on Tuesday, October 4th. The shares were sold at an average price of $16.21, for a total value of $56,735.00. Following the sale, the chief executive officer now owns 1,526,505 shares of the company’s stock, valued at $24,744,646.05. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Howard E. Rubin sold 4,369 shares of the business’s stock in a transaction on Monday, August 22nd. The stock was sold at an average price of $14.94, for a total transaction of $65,272.86. Following the completion of the sale, the director now directly owns 168,055 shares in the company, valued at approximately $2,510,741.70. The disclosure for this sale can be found here.

Several hedge funds have recently modified their holdings of TRUP. AQR Capital Management LLC acquired a new stake in shares of Trupanion during the second quarter valued at $146,000. Metropolitan Life Insurance Co. NY acquired a new stake in shares of Trupanion during the second quarter valued at $160,000. A.R.T. Advisors LLC acquired a new stake in shares of Trupanion during the second quarter valued at $166,000. Alliancebernstein L.P. acquired a new stake in shares of Trupanion during the second quarter valued at $168,000. Finally, Thompson Davis & CO. Inc. acquired a new stake in shares of Trupanion during the second quarter valued at $181,000.

Shares of Trupanion (NYSE:TRUP) traded up 0.06% during mid-day trading on Thursday, reaching $16.00. The company had a trading volume of 71,995 shares. The firm’s market capitalization is $464.24 million. The stock has a 50 day moving average of $16.00 and a 200-day moving average of $14.16. Trupanion has a one year low of $6.27 and a one year high of $17.68.

Trupanion (NYSE:TRUP) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.06. The firm had revenue of $45.83 million for the quarter, compared to analyst estimates of $45.05 million. During the same quarter in the prior year, the firm earned ($0.17) earnings per share. The firm’s revenue for the quarter was up 28.8% on a year-over-year basis. Equities analysts predict that Trupanion will post ($0.22) EPS for the current year.

About Trupanion

Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.

5 Day Chart for NYSE:TRUP

Receive News & Stock Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related stocks with our FREE daily email newsletter.